Group 1 - The company announced a share repurchase plan with a total expected amount between 75 million and 150 million RMB, with a repurchase period from September 20, 2024, to September 19, 2025 [1] - The repurchase is intended for employee stock ownership plans or equity incentives, with a maximum repurchase price set at 5.00 RMB per share [1] - As of June 20, 2025, the company has repurchased a total of 20,592,200 shares, accounting for 1.001% of the total share capital, with a total expenditure of 80,457,115.00 RMB [3] Group 2 - The company held a board meeting on October 18, 2024, to change the purpose of the repurchased shares from solely for employee stock ownership plans to include equity incentives [2] - Following the distribution of cash dividends, the maximum repurchase price was adjusted from 5.00 RMB to 4.99 RMB per share on January 24, 2025, and further adjusted to 4.96 RMB on June 17, 2025 [2][3] - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations regarding the progress of the share repurchase [4]

| | | 公告编号：2025-050 | | --- | --- | --- | | 证券代码：605020 | 证券简称：永和股份 | | 债券代码：111007 债券简称：永和转债 浙江永和制冷股份有限公司 关于调整股票期权行权价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 由 22.60 元/股调整为 22.35 元/股。现对有关事项说明如下： 一、2021 年股票期权与限制性股票激励计划已履行的审议程序 浙江永和制冷股份有限公司（以下简称"公司"）于 2025 年 6 月 19 日召开 第四届董事会第十九次会议及第四届监事会第十六次会议，审议通过了《关于调 整股票期权行权价格的议案》，同意将公司首次及预留授予部分股票期权行权价格 <浙江永和制冷股份有限公司 ensp="ensp" 年股票期权与限制性股票激励计划="年股票期权与限制性股 票激励计划" 草案="草案"> 及其 摘要的议案》《关于 <浙江永和制冷股份有限公司 ensp="ensp" 年股票期权与限制性股票激="年股票期 权与限制性股票激"> ...

Core Viewpoint - The new FDA regulation mandating the addition of taurine in infant formula and pet food has significantly impacted the global food industry, leading to a surge in demand and prices for taurine, with Chinese company Yong'an Pharmaceutical becoming a key player in this market [1][3]. Group 1: Market Dynamics - The price of food-grade taurine skyrocketed by 75% within a month, with quotes reaching 25,000 yuan per ton, compared to 13,000 yuan per ton in March 2025 [3]. - The global taurine market is characterized by a supply-demand imbalance, with an annual demand of approximately 160,000 tons and existing production capacity of only 140,000 tons, resulting in a supply gap of about 20,000 tons [9]. Group 2: Company Positioning - Yong'an Pharmaceutical holds over 90% of the global taurine production capacity and is the only company with FDA and EFSA certifications, allowing it to charge a premium price of 82,000 USD per ton for its pharmaceutical-grade taurine [10]. - The company has seen a 120% year-on-year increase in exports of its pharmaceutical-grade products to the US and EU markets [10]. Group 3: Industry Trends - The demand for taurine is driven by various applications, including functional beverages and high-end pet food, with the young consumer demographic in China showing a 20% annual growth in taurine consumption [5]. - The pet food market has seen a penetration rate of over 35% for premium products, with some cat food containing taurine levels ten times higher than those for humans [5]. Group 4: Competitive Landscape - The taurine industry is highly concentrated, with three main players: Yong'an Pharmaceutical, Shengyuan Environmental Protection, and New Hecheng, which together dominate the market [9]. - Shengyuan Environmental Protection is set to launch a new 40,000-ton food-grade taurine project in the second half of 2025, potentially altering the competitive dynamics in the mid-to-low-end market [13].

证券代码：000912 证券简称：泸天化 公告编号：2025-040 四川泸天化股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性 陈述或重大遗漏。 四川泸天化股份有限公司（以下简称"公司"）于2024年6月20日召开2023 年度股东大会，审议通过了《四川泸天化股份有限公司回购股份方案》，同意公 司使用自有资金以集中竞价交易方式回购公司部分股份，回购资金总额不低于人 民币8,000万元（含），不超过人民币15,000万元（含），回购价格不超过人民 币6.09元/股（含本数），本次回购股份将用于股权激励。本次回购股份的实施 期限自2023年度股东大会审议通过回购股份方案之日起12个月内（2025年6月19 日止）。具体回购股份的金额和数量以回购结束时实际回购的金额和股份数量为 准。公司已在中国证券登记结算有限责任公司深圳分公司开立股份回购专用证券 账户并披露了《回购报告书》。 截至本公告披露日，公司本次回购股份计划已实施完毕。根据《上市公司股 份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》 等相关规定，现将公司本次回购结果公告如下： 一、回购股份 ...

? 本次担保金额及已实际为其提供的担保余额：公司本次为浙江染化提供 最高额保证，担保的最高债权额为人民币 12.01 亿元（其中在招商银行担保的最 高债权额为人民币 4.5 亿元，在民生银行担保的最高债权额为人民币 2 亿元，在 绍兴银行担保的最高债权额为人民币 1.81 亿元，在杭州银行担保的最高债权额 为人民币 2.2 亿元，在浙商银行担保的最高债权额为人民币 1.5 亿元）及其利息、 费用等；为浙江鸿盛提供最高额保证，担保的最高债权额为人民币 9.2 亿元（其 中在招商银行担保的最高债权额为人民币 4 亿元，在民生银行担保的最高债权额 为人民币 1 亿元，在杭州银行担保的最高债权额为人民币 2.2 亿元，在浙商银行 担保的最高债权额为人民币 2 亿元）及其利息、费用等；为浙江安诺提供最高额 保证，担保的最高债权额为人民币 2 亿元及其利息、费用等；为浙江科永提供最 高额保证，担保的最高债权额为人民币 0.89 亿元及其利息、费用等；为浙江恩 盛提供最高额保证，担保的最高债权额为人民币 0.5 亿元及其利息、费用等。截 至 2025 年 6 月 14 日，公司实际为浙江染化担保余额人民币 29.54 亿元 ...

公司于 2023 年 6 月 30 日收到中国银行间市场交易商协会核发的《接受注册通 知书》（中市协注2023DFI36 号），中国银行间市场交易商协会接受公司债务融 资工具注册，注册自通知书落款之日起 2 年内有效，在注册有效期内可分期发行超 短期融资券、短期融资券、中期票据、永续票据、资产支持票据、绿色债务融资工 具等产品。 公司根据自身资金计划安排和银行间市场情况，于 2025 年 6 月 12 日在全国银 行间市场发行了 2025 年度第六期科技创新债券，募集资金已于 2025 年 6 月 13 日 到账。发行结果如下： | | 万华化学集团股份有限公司2025年 | | 25万华化学 MTN006(科创 | | --- | --- | --- | --- | | 名称 | | 简称 | | | | 度第六期科技创新债券 | | 债) | | 代码 | 102582405 | 期限 | 3年 | | 起息日 | 2025年06月13日 | 兑付日 | 2028年06月13日 | | 计划发行总额 | 12亿元 | 实际发行总额 | 12亿元 | | 发行利率 | 1.83% | 发行价格 | 100元 ...

Group 1 - The photoresist concept sector increased by 1.45%, ranking second in the concept sector's growth, with 43 stocks rising, including Strong New Materials which hit the daily limit of 20% [1] - Notable gainers in the photoresist sector include Jingrui Electric Materials, Yanggu Huatai, and Jiaxian Co., which rose by 11.25%, 9.11%, and 6.86% respectively [1] - The sector saw a net inflow of 857 million yuan from main funds, with 38 stocks receiving net inflows, and 7 stocks exceeding 50 million yuan in net inflow [2] Group 2 - Strong New Materials led the net inflow with 461 million yuan, followed by Jingrui Electric Materials, Kent Catalysts, and Yanggu Huatai with net inflows of 98.38 million yuan, 78.77 million yuan, and 71.71 million yuan respectively [2][3] - The net inflow ratios for Kent Catalysts, Strong New Materials, and Baichuan Co. were 29.65%, 27.48%, and 10.77% respectively, indicating strong investor interest [3]

Core Points - Xinghua Co., Ltd. experienced a limit down on the trading day, with a turnover rate of 9.08% and a total transaction amount of 468 million yuan, reflecting a price fluctuation of 9.67% [2] - Institutional investors net sold 98,900 yuan, while the total net selling by brokerage seats amounted to 4.87 million yuan [2] - The stock was listed on the Shenzhen Stock Exchange due to a daily price deviation of -9.40% [2] Trading Data - The top five brokerage seats accounted for a total transaction amount of 75.65 million yuan, with buying transactions at 35.34 million yuan and selling transactions at 40.31 million yuan, resulting in a net selling of 4.97 million yuan [2] - Among the brokerage seats, two institutional specialized seats were involved, with a total buying amount of 7.55 million yuan and a selling amount of 7.64 million yuan, leading to a net selling of 9,890 yuan [2] Fund Flow - The stock saw a net inflow of 2.72 million yuan from main funds, with a net outflow of 930,200 yuan from large orders and a net inflow of 3.65 million yuan from major orders [2] - Over the past five days, the main funds experienced a net outflow of 120 million yuan [2]

Core Viewpoint - The company is preparing for its 2024 annual shareholder meeting, focusing on the approval of the 2024 financial report and dividend distribution plan, amidst a challenging economic environment that has impacted its profitability [1][35]. Meeting Details - The shareholder meeting is scheduled for June 26, 2025, at 14:00, with both on-site and online voting options available [1]. - The meeting will be hosted by the company's chairman, Mr. Luo Liguo [1]. Shareholder Rights and Responsibilities - Shareholders are entitled to various rights, including speaking, questioning, and voting, and must adhere to the meeting's order and regulations [2][3]. - Shareholders must register and provide valid identification to participate in the meeting [2]. Financial Performance - In 2024, the company reported a revenue of RMB 26.69 billion, a slight increase of 0.41% year-on-year, but net profit decreased by 33.64% to RMB 1.74 billion due to economic fluctuations and declining product prices [12][33]. - The company’s total assets reached RMB 90.77 billion, reflecting an 8.91% increase from the previous year [33]. Operational Highlights - The company maintained its leading position in the industrial silicon and organic silicon sectors through refined management and technological innovation, achieving stable gross margins despite market price fluctuations [8][12]. - Significant projects include the production line for high-purity polysilicon and the carbon silicon particle project, which have commenced operations [8]. Research and Development - The company is enhancing its R&D capabilities, focusing on high-value downstream products and breaking through technological barriers in key materials [9][10]. - Investments in R&D are aimed at developing new products for emerging sectors such as 5G and electric vehicles [24]. Sustainability Initiatives - The company is committed to green development, aligning with national carbon reduction strategies, and is implementing measures to enhance energy efficiency and reduce carbon emissions [12][25]. - A digital transformation strategy is being pursued to improve operational efficiency and sustainability across the supply chain [11][25]. Future Plans - The company plans to optimize production management, enhance resource allocation, and continue investing in core business areas to maintain competitive advantages [23][24]. - Key initiatives for 2025 include strengthening the innovation management system and advancing digital transformation efforts [24][25].

期货研究 烧碱：现货承压，趋势偏弱 陈嘉昕 投资咨询从业资格号：Z0020481 chenjiaxin023887@gtjas.com 【基本面跟踪】 烧碱基本面数据 09合约期货价格 山东最便宜可交割 现货32碱价格 山东现货32碱折盘面 基差 2288 830 2594 306 2025 年 6 月 20 日 资料来源：隆众资讯，国泰君安期货 【现货消息】 山东地区主要氧化铝厂家采购 32%离子膜碱自 6 月 20 日起价格下调 20 元/吨，执行出厂 780 元/吨。 【市场状况分析】 高利润，高产量的格局将始终影响烧碱，做空烧碱利润将变成年度级别的策略和主逻辑。魏桥持续下调 采购价格，在现货有降价预期时，下游和贸易商的囤货需求明显放缓，加剧市场负反馈。同时，由于现货的 快速下跌，近月多头接货压力加剧，近月补贴水的逻辑也难以支撑市场。 在利润或被持续压缩的背景下，烧碱也不是没有反弹的空间，从历史的角度看，近三年季节性旺季都出 现过 1000 元/吨以上的利润。主要因为液体化工品短期供需错配带来的巨大价格弹性。 下半年重点关注氧化铝和出口方向的囤货，非铝环节金九银十的备货。全国样本库存 30 万吨以下，烧 ...